Location: Burbidge Building
5968 College Street
PO Box 15000
Halifax, NS B3H 4R2
Telephone: (902) 494-2378
Fax: (902) 494-1396

Director of College

Caldwell, R. K., BSc (Pharm), MHSA (Dalhousie)

Associate Director Research

Sketris, I. S., BSc (Pharm) (Toronto), PharmD (Minn), MPA (HSA) (Dalhousie)

Graduate Coordinator

Jakeman, D. L., BSc, PhD (Sheffield)


Jakeman, D. L., BSc, PhD (Sheffield). Applications of enzymes and carbohydrates, protein engineering, medicinal chemistry.
Yeung, P. K. F., BSc (Pharm), MSc (Man), PhD (Sask). Pharmacokinetics, Drug Metabolism, and Biomarker Assessment.

Associate Professors

Agu, R., BPharm, MPharm (Pharmacology) (U Nigeria), MPharm (Pharmaceutics), PhD (Biopharmaceutics) (Katholieke Universiteit, Belgium)
Goralski, K., BSc (Biochem/Micro), PhD (Pharmacology and Therapeutics) (Manitoba)
Jurgens, T., BSc (Pharm), MSc (Dalhousie), PhD (Miss)
Massoud, E., MB, BCh (Cairo), MSc (Cairo), FRCSC (Royal College), Major Appointment in Surgery, Faculty of Medicine.


The goal of the Master of Science degree in Pharmaceutical Sciences program is to educate students to become high quality research-based scientists who can contribute to drug discovery and development in academia and the pharmaceutical industry.

I. Admission Requirements

Candidates must satisfy the general requirements for admission to the Faculty of Graduate Studies. More specifically, the admission requirements and standards will be as follows:

1. Any international student, as applicable, will be required to demonstrate an ability to communicate and write in English (TOEFL > 600).
2. At least two letters of support.
3. Appropriate academic background. Students will be considered for acceptance into the Master of Science in Pharmaceutical Sciences via:
  i) a completed BSc (Pharm) or PharmD degree with a suitable letter of recommendation from a faculty member with first-hand knowledge of the potential students academic abilities.
  ii) a completed BSc (honors) degree (or equivalent demonstrated research experience) in a related scientific field, not limited to: pharmacology, biochemistry, chemistry, microbiology, chemical or biochemical engineering, with a suitable letter of recommendation from a faculty member with first-hand knowledge of the potential students academic abilities (e.g. thesis supervisor).
  iii) a completed MD, DVSc, DDS, or equivalent with demonstrated research experience with a suitable letter of recommendation from a faculty member with first-hand knowledge of the potential students academic abilities (e.g. thesis supervisor).

Students without these prerequisites, that wish to be accepted into the program, may enroll in specific courses at Dalhousie in consultation with a potential graduate supervisor, in order to demonstrate their ability and aptitude. Subsequent entry into the MSc (Pharmaceutical Sciences) in a later academic year will be dependent upon satisfactory performance in the chosen courses and is not guaranteed.


General Regulations

All graduate students are required to carry out novel, original research. In addition, all graduate students are required, as part of their training, to present and participate in graduate student seminars, and to attend invited speaker seminars. The learning outcomes of this program are as follows:


a. Students will be competent in performing general laboratory techniques as well as techniques specific to their chosen area of research.
b. Students will be able to develop and execute a research project.
c. Students will develop scientific writing skills through the writing of a thesis and scientific paper(s) that result from their research.
d. Students will develop oral presentation skills through their participation in the seminar series and thesis committee meetings.
e. Students will develop the ability and confidence to clearly and succinctly communicate the results of their research to the scientific community.
f. Students will develop clinical thinking skills required of a researcher.

II. Degree Options

MSc Degree

Full-time Program
The Master of Science in Pharmaceutical Sciences program will normally be completed in two years of full-time study. Candidates must satisfactorily complete PHAR 5001.03 and a minimum of two of the elective courses. Candidates will be permitted to select alternative courses with the permission of the Graduate Coordinator and Research Supervisor. In addition, all students will be required to take the Integrated Health Research Training Program ( There will be no credit provided for this seminar series but there will be a notation on the student's transcription following successful completion. Following completion of these courses, the students will complete PHAR 9000.00, their MSc thesis. The program will be structured using a combination of courses and thesis-based research, with a supervisor and supervisory committee overseeing progress. Financial support is available for all students accepted into the program, either from the student's supervisor, funding within and available to the College of Pharmacy, or a combination of these sources.

Part-time Program
The full-time MSc course requirements and thesis regulations apply. The thesis must be supervised by a member of the College of Pharmacy.

III. Course Descriptions

A core graduate course (5001) and advanced courses (6000) are offered. The core course constitutes the main framework of a student's formal course work, and is designed to be broad-based but at an advanced level. It is intended to help the student gain a wide understanding in several major areas of the pharmaceutical sciences and thus students are strongly encouraged to take some courses outside their area of specialization. Specialized courses provide the opportunity for in-depth study of selected topics which are more closely related to the student's research area.

PHAR 5001.03: Pharmaceutical Sciences “From Drug Discovery to Therapeutics”.

PHAR 6010.03: The Chemistry and Pharmacology of Bioactive Compounds from Plants.

PHAR 6030.03: Drug Transporters in Pharmacology and Therapeutics.

PHAR 6040.03: Pharmacokinetics, Metabolism and Biomarker for Preclinical and Clinical Drug Development.

PHAR 6050.03: Biopharmaceutical Aspects of Preclinical Drug Development.

PHAR 6080.03: Chemical Biology: Understanding Biological Processes using Chemical Approaches.

PHAR 9000.00: MSC Thesis.